Shattuck Labs Inc (STTK)

$7.04

up-down-arrow $-0.61 (-7.97%)

As on 28-Aug-2026 16:00EDT

Market cap

info icon

$707 Mln

Revenue (TTM)

info icon

$1 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

3.6

Div. Yield

info icon

0 %

Shattuck Labs Inc (STTK) Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 7.04 High: 7.59

52 Week Range

Low: 0.97 High: 8.33

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -0.4 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    --

  • EV/EBITDAEV/EBITDA information

    -3.6

  • Debt to EquityDebt to Equity information

    0

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $-0.5

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    100,363,253

6 Years Aggregate

CFO

$-294.38 Mln

EBITDA

$-297.10 Mln

Net Profit

$-298.92 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Shattuck Labs Inc (STTK)
92.9 0.0 16.2 604.0 48.7 -19.6 --
BSE Sensex*
-9.1 -1.2 2.9 -3.6 5.7 6.2 10.5
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 28-Aug-2026  |  *As on 31-Aug-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
2021
Shattuck Labs Inc (STTK)
201.7 -82.8 210.0 -73.0 -83.8
S&P Small-Cap 600
4.0 7.0 13.9 -17.4 25.3
BSE Sensex
9.1 8.1 18.7 4.4 22.0

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Shattuck Labs Inc (STTK)
7.0 706.6 1.0 -52.6 -5,256.8 -35.8 -- 3.6
84.9 11,993.9 669.5 -320.0 -0.8 -71.1 -- 26.9
72.1 10,022.2 71.0 -894.0 -1,175.8 -- -- 60.3
54.5 13,491.7 2,435.9 860.6 31.0 43 17.4 7.4
105.4 11,957.0 1,663.7 413.6 36.3 430 30.9 84.5
351.5 10,402.8 440.5 241.5 33.4 18.7 44.1 7.8
533.8 12,332.1 1,283.9 -325.1 -19.0 -57.7 -- 24.0
600.7 16,765.1 2,782.3 491.5 21.1 110.1 35.2 39.3
344.8 9,625.4 0.0 -339.1 -- -30.6 -- 7.6
144.3 9,339.4 282.0 82.9 -28.6 11.4 140.1 11.5

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Shattuck Labs Inc (STTK)

Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking...  monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas. 

  • Co-Founder, CEO & Director

    Dr. Taylor H. Schreiber M.D., Ph.D.

  • Co-Founder, CEO & Director

    Dr. Taylor H. Schreiber M.D., Ph.D.

  • Headquarters

    Austin, TX

  • Website

    https://www.shattucklabs.com

FAQs for Shattuck Labs Inc (STTK)

The share price of Shattuck Labs Inc (STTK) is $7.04 (NASDAQ) as of 28-Aug-2026 16:00 EDT. Shattuck Labs Inc (STTK) has given a return of 48.73% in the last 3 years.

Since, TTM earnings of Shattuck Labs Inc (STTK) is negative, P/E ratio is not available.
The P/B ratio of Shattuck Labs Inc (STTK) is 3.63 times as on 28-Aug-2026, a 30 discount to its peers’ median range of 5.18 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
-7.76
4.60
2024
-0.82
0.77
2023
-3.51
2.12
2022
-0.97
0.55
2021
-8.46
1.40

The 52-week high and low of Shattuck Labs Inc (STTK) are Rs 8.33 and Rs 0.97 as of 31-Aug-2026.

Shattuck Labs Inc (STTK) has a market capitalisation of $ 707 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Shattuck Labs Inc (STTK), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...